Investor profile
Capricorn Partners
See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
Capricorn Partners is an independent European manager of venture capital funds and Quest for Growth, focused on innovative companies that use technology as a competitive advantage. The firm concentrates on three core themes — digital (AI, IoT, digital twin, data science applied to Business 4.0 and digital health), health (digital health, medtech, and pharma/biotech), and cleantech (sustainable chemistry, circular economy, green materials, and industrial biotech) — investing primarily across Europe with a special focus on the Benelux region. Capricorn targets companies from late seed through Series B, typically deploying initial tickets of €1–5 million, and seeks businesses where technology or intellectual property serves as a genuine differentiating factor, avoiding 'me-too' products in favour of disruptive innovations with the potential to address global markets and generate positive societal impact alongside financial returns.
Notable quotes
“Our team believes in technology as an enabler to solve societal problems. What makes the venture capital world so exciting is you can really make a difference for the right entrepreneur with the right idea.”
“We invest in companies where technology or intellectual property serves as a differentiating factor. We generally avoid companies with 'me-too' products that focus on marginal improvements. We focus on themes like digital health and cleantech, where we see the potential for substantial impact.”
“We were actually impact investors avant la lettre. Because of the high risks we took, we were obliged to seek extra returns, but we also decided to only invest in matters that were positive for people and society. Ultimately, return is also a requirement to be durable.”
Team
Sabine Vermassen
Managing Partner
Steven Lambert
Investment Partner Digital
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| Endo Tools Therapeutics | Series C | $23m | 2026-07-16 |
| Trillium Renewable Chemicals | Series B | $13m | 2026-05-05 |
| Rocsys | Series A | $13m | 2026-04-29 |
| Conxai | Seed | — | 2026-04-07 |
| Oska Health | Series A | $11m | 2026-02-26 |
| Xyall | Series A | $8m | 2026-02-11 |
| Trendtracker | Series A | $7m | 2025-12-11 |
| Confo Therapeutics | Series B | — | 2024-07-26 |
| Icometrix | Series B | — | — |
| DMC Biotechnologies | Series B | $34m | 2021-12-02 |
Frequent co-investors
Fit check
Is Capricorn Partners a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit